XML 98 R87.htm IDEA: XBRL DOCUMENT v3.25.2
Debt Obligations - Life Sciences Narrative (Details) - USD ($)
3 Months Ended 6 Months Ended
Jan. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Aug. 01, 2025
Jul. 31, 2025
Jul. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Jan. 30, 2024
Debt Instrument [Line Items]                      
Accrued interest and exit fees (current portion)   $ 74,000,000.0   $ 74,000,000.0           $ 61,000,000.0  
Total aggregate finance lease and debt payments   641,300,000   641,300,000           668,300,000  
Life Sciences                      
Debt Instrument [Line Items]                      
Total aggregate finance lease and debt payments   $ 26,500,000   $ 26,500,000           24,000,000.0  
Life Sciences | 20.00% Notes                      
Debt Instrument [Line Items]                      
Interest rate   20.00%   20.00%              
R2 Technologies | Related Party | Life Sciences                      
Debt Instrument [Line Items]                      
Interest cost relating to contractual interest coupon   $ 5,200,000 $ 1,000,000 $ 9,700,000 $ 1,900,000            
R2 Technologies | Related Party | Life Sciences | 20.00% Notes                      
Debt Instrument [Line Items]                      
Interest rate 20.00% 20.00%   20.00%              
Face amount $ 20,000,000                    
Short-term debt   $ 26,500,000   $ 26,500,000           24,000,000.0  
Accrued interest and exit fees (current portion) $ 2,600,000                    
Exit fee percentage 10.50%     12.92%              
Exit fees $ 2,200,000     $ 8,700,000              
Debt covenant, maturity, number of days after event 5 days                    
Debt covenant, proceeds received amount to cause debt maturity $ 20,000,000                    
Optional prepayment, number of days written notice 5 days                    
Additional exit fee payable                 $ 1,000,000    
Increase in exit fee per month                 $ 1,000,000    
Increase in exit fee percentage   0.17%   0.17%              
Exit fees (non-current portion)   $ 16,500,000   $ 16,500,000           7,900,000  
Interest costs capitalized       2,500,000              
Outstanding debt   41,600,000   41,600,000           $ 31,900,000  
Unamortized discount   $ 1,400,000   $ 1,400,000              
Interest rate, effective percentage   51.30%   51.30%           57.80%  
R2 Technologies | Related Party | Life Sciences | 20.00% Notes | Subsequent Event                      
Debt Instrument [Line Items]                      
Interest rate             12.00% 20.00%      
Face amount               $ 20,000,000      
Additional exit fee payable           $ 5,000,000          
R2 Technologies | Related Party | Life Sciences | 20.00% Senior Notes Due 2024                      
Debt Instrument [Line Items]                      
Interest rate                     20.00%
Short-term debt                     $ 17,400,000